Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $16,059 | 3 | 91.1% |
| Food and Beverage | $1,565 | 86 | 8.9% |
| Education | $13.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| USWM, LLC | $16,238 | 14 | $0 (2023) |
| Alkermes, Inc. | $424.15 | 19 | $0 (2024) |
| Indivior Inc. | $420.10 | 23 | $0 (2024) |
| Braeburn Inc. | $207.09 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $65.75 | 3 | $0 (2024) |
| AbbVie Inc. | $64.03 | 3 | $0 (2023) |
| ITI, Inc. | $34.08 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $26.34 | 2 | $0 (2023) |
| PFIZER INC. | $23.63 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $22.04 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.25 | 20 | Braeburn Inc. ($139.61) |
| 2023 | $16,010 | 23 | USWM, LLC ($15,656) |
| 2022 | $854.24 | 24 | USWM, LLC ($581.95) |
| 2021 | $63.67 | 3 | Indivior Inc. ($43.17) |
| 2020 | $219.53 | 8 | Alkermes, Inc. ($186.91) |
| 2019 | $133.21 | 9 | Alkermes, Inc. ($95.83) |
| 2018 | $28.53 | 2 | Indivior Inc. ($28.53) |
| 2017 | $12.04 | 1 | AstraZeneca Pharmaceuticals LP ($12.04) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Opioid Use Disorder | ||||||
| 11/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: OUD | ||||||
| 11/01/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: CNS | ||||||
| 10/03/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: Opioid Use Disorder | ||||||
| 09/18/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Opioid Use Disorder | ||||||
| 08/30/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: OUD | ||||||
| 08/16/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Opioid Use Disorder | ||||||
| 08/16/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: Opioid Use Disorder | ||||||
| 06/25/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: OUD | ||||||
| 05/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Opioid Use Disorder | ||||||
| 05/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Opioid Use Disorder | ||||||
| 04/25/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: OUD | ||||||
| 04/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Neuropsychiatry | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: VACCINES | ||||||
| 03/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Opioid Use Disorder | ||||||
| 03/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Opioid Use Disorder | ||||||
| 02/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Opioid Use Disorder | ||||||
| 01/23/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: OUD | ||||||
| 01/13/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Opioid Use Disorder | ||||||
| 12/21/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Opioid Use Disorder | ||||||
| 12/08/2023 | Merck Sharp & Dohme LLC | PROQUAD (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: VACCINE | ||||||
| 11/15/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: OUD | ||||||
| 10/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Opioid Use Disorder | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 301 | 470 | $98,070 | $34,613 |
| 2022 | 7 | 163 | 269 | $53,944 | $17,896 |
| 2021 | 13 | 353 | 520 | $93,608 | $33,635 |
| 2020 | 17 | 572 | 851 | $160,824 | $52,946 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 234 | $37,206 | $13,626 | 36.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $18,858 | $5,423 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 50 | $11,550 | $3,520 | 30.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,741 | $3,375 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 40 | $5,880 | $2,330 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $5,678 | $2,028 | 35.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 30 | 32 | $6,464 | $1,886 | 29.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 20 | $4,520 | $1,771 | 39.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $612.00 | $341.28 | 55.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $561.00 | $312.84 | 55.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 111 | $17,649 | $6,083 | 34.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 26 | $11,674 | $3,807 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 37 | $8,547 | $2,588 | 30.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 31 | $7,006 | $2,418 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 29 | $4,263 | $1,490 | 35.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 20 | 20 | $4,040 | $1,102 | 27.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $765.00 | $408.35 | 53.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 163 | $26,127 | $8,768 | 33.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 40 | $18,248 | $6,004 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 56 | $12,936 | $4,728 | 36.5% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 11 | 11 | $6,721 | $4,407 | 65.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 43 | $6,321 | $2,669 | 42.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 22 | $5,126 | $1,721 | 33.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 31 | 32 | $6,592 | $1,688 | 25.6% |
| 99458 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute | Office | 2021 | 14 | 31 | $3,813 | $1,119 | 29.4% |
About Dr. Grant Studebaker, MD
Dr. Grant Studebaker, MD is a Family Medicine healthcare provider based in Jackson, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2013. The National Provider Identifier (NPI) number assigned to this provider is 1265774236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Studebaker, MD has received a total of $17,637 in payments from pharmaceutical and medical device companies, with $315.25 received in 2024. These payments were reported across 90 transactions from 17 companies. The most common payment nature is "Gift" ($16,059).
As a Medicare-enrolled provider, Studebaker has provided services to 1,389 Medicare beneficiaries, totaling 2,110 services with total Medicare billing of $139,089. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Jackson, TN
- Active Since 03/18/2013
- Last Updated 08/24/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265774236
Products in Payments
- ZIMHI (Drug) $16,090
- SUBLOCADE (Drug) $420.10
- Vivitrol (Drug) $248.67
- BRIXADI (Drug) $207.09
- VIVITROL (Drug) $155.85
- Lucemyra (Drug) $148.19
- VRAYLAR (Drug) $64.03
- BEXSERO (Biological) $43.40
- CAPLYTA (Drug) $34.08
- NURTEC ODT (Drug) $23.63
- AREXVY (Drug) $22.35
- INGREZZA (Drug) $22.04
- INJECTAFER (Drug) $20.50
- SYNAGIS (Drug) $20.09
- ARISTADA (Drug) $19.63
- PROQUAD (Biological) $13.92
- XARELTO (Drug) $13.91
- ZIO Patch (Device) $12.53
- GARDASIL 9 (Biological) $12.42
- NUEDEXTA (Drug) $12.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jackson
Dr. Matt Rosenberg, M.d, M.D
Family Medicine — Payments: $677,942
Dr. Andrea Phillips, M.c, M.C
Family Medicine — Payments: $84,561
Dr. Krishan Gupta, M.d, M.D
Family Medicine — Payments: $26,295
Charles Pewitt, Do, DO
Family Medicine — Payments: $25,061
Alexander Osowa, Md, MD
Family Medicine — Payments: $22,911
Dr. Channing Smith, M.d, M.D
Family Medicine — Payments: $22,627